Glucagon‐Like Peptide‐1 Receptor Agonists in Type 1 Diabetes: The Importance of Identifying the Insulin‐Resistant Type 1 Diabetes Phenotype, and Differentiating Early and Newer Generation Therapies

Jerry R. Greenfield, Ruth Frampton, Jennifer R. Snaith

doi:10.1111/dom.71505

CrossrefInfo card

Glucagon‐Like Peptide‐1 Receptor Agonists in Type 1 Diabetes: The Importance of Identifying the Insulin‐Resistant Type 1 Diabetes Phenotype, and Differentiating Early and Newer Generation Therapies

Jerry R. Greenfield, Ruth Frampton, Jennifer R. Snaith

Diabetes, Obesity and Metabolism · 2026-11-03

DOI: 10.1111/dom.71505 ↗

Abstract Bibliographic details

Abstract

No abstract available.

Bibliographic details

Authors: Jerry R. Greenfield, Ruth Frampton, Jennifer R. Snaith
Journal: Diabetes, Obesity and Metabolism
Year of publication: 2026
Publisher: Wiley
DOI: 10.1111/dom.71505
ISSN: 1462-8902; 1463-1326
Source: Crossref

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.